Annual EBITDA
-$19.93 M
+$4.07 M+16.97%
December 31, 2023
Summary
- As of February 7, 2025, ERNA annual EBITDA is -$19.93 million, with the most recent change of +$4.07 million (+16.97%) on December 31, 2023.
- During the last 3 years, ERNA annual EBITDA has fallen by -$12.78 million (-178.80%).
- ERNA annual EBITDA is now -178.80% below its all-time high of -$7.15 million, reached on December 1, 2020.
Performance
ERNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$24.45 M
-$20.30 M-489.14%
September 30, 2024
Summary
- As of February 7, 2025, ERNA quarterly EBITDA is -$24.45 million, with the most recent change of -$20.30 million (-489.14%) on September 30, 2024.
- Over the past year, ERNA quarterly EBITDA has dropped by -$19.30 million (-374.85%).
- ERNA quarterly EBITDA is now -2366.46% below its all-time high of -$991.50 thousand, reached on March 1, 2020.
Performance
ERNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$39.07 M
-$19.49 M-99.49%
September 30, 2024
Summary
- As of February 7, 2025, ERNA TTM EBITDA is -$39.07 million, with the most recent change of -$19.49 million (-99.49%) on September 30, 2024.
- Over the past year, ERNA TTM EBITDA has dropped by -$19.67 million (-101.41%).
- ERNA TTM EBITDA is now -3840.70% below its all-time high of -$991.50 thousand, reached on March 1, 2020.
Performance
ERNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ERNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.0% | -374.9% | -101.4% |
| 3 y3 years | -178.8% | -365.4% | -95.1% |
| 5 y5 years | -178.8% | -365.4% | -95.1% |
ERNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.7% | -656.4% | at low | -110.0% | +68.0% |
| 5 y | 5-year | -178.8% | +83.7% | -2366.5% | +71.5% | -3840.7% | +68.0% |
| alltime | all time | -178.8% | +83.7% | -2366.5% | +71.5% | -3840.7% | +68.0% |
Eterna Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.45 M(+489.1%) | -$39.07 M(+99.5%) |
| Jun 2024 | - | -$4.15 M(-21.9%) | -$19.59 M(+0.6%) |
| Mar 2024 | - | -$5.32 M(+3.2%) | -$19.46 M(+0.3%) |
| Dec 2023 | -$19.93 M(-17.0%) | -$5.15 M(+3.6%) | -$19.40 M(+4.3%) |
| Sep 2023 | - | -$4.97 M(+23.4%) | -$18.61 M(-10.6%) |
| Jun 2023 | - | -$4.03 M(-23.4%) | -$20.82 M(+4.0%) |
| Mar 2023 | - | -$5.25 M(+20.6%) | -$20.02 M(-16.6%) |
| Dec 2022 | -$24.01 M | -$4.36 M(-39.3%) | -$24.01 M(-12.4%) |
| Sep 2022 | - | -$7.18 M(+122.1%) | -$27.40 M(-74.2%) |
| Jun 2022 | - | -$3.23 M(-65.0%) | -$106.06 M(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$9.24 M(+19.2%) | -$112.77 M(-7.5%) |
| Dec 2021 | -$121.95 M(+1605.6%) | - | - |
| Dec 2021 | - | -$7.75 M(-91.0%) | -$121.95 M(+4.8%) |
| Sep 2021 | - | -$85.84 M(+763.1%) | -$116.38 M(+257.8%) |
| Jun 2021 | - | -$9.95 M(-46.0%) | -$32.52 M(+32.4%) |
| Mar 2021 | - | -$18.41 M(+744.0%) | -$24.57 M(+243.7%) |
| Dec 2020 | -$7.15 M | -$2.18 M(+10.1%) | -$7.15 M(+43.9%) |
| Sep 2020 | - | -$1.98 M(-0.6%) | -$4.97 M(+66.4%) |
| Jun 2020 | - | -$1.99 M(+101.2%) | -$2.99 M(+201.2%) |
| Mar 2020 | - | -$991.50 K | -$991.50 K |
FAQ
- What is Eterna Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Eterna Therapeutics?
- What is Eterna Therapeutics annual EBITDA year-on-year change?
- What is Eterna Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly EBITDA year-on-year change?
- What is Eterna Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Eterna Therapeutics?
- What is Eterna Therapeutics TTM EBITDA year-on-year change?
What is Eterna Therapeutics annual EBITDA?
The current annual EBITDA of ERNA is -$19.93 M
What is the all time high annual EBITDA for Eterna Therapeutics?
Eterna Therapeutics all-time high annual EBITDA is -$7.15 M
What is Eterna Therapeutics annual EBITDA year-on-year change?
Over the past year, ERNA annual EBITDA has changed by +$4.07 M (+16.97%)
What is Eterna Therapeutics quarterly EBITDA?
The current quarterly EBITDA of ERNA is -$24.45 M
What is the all time high quarterly EBITDA for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly EBITDA is -$991.50 K
What is Eterna Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ERNA quarterly EBITDA has changed by -$19.30 M (-374.85%)
What is Eterna Therapeutics TTM EBITDA?
The current TTM EBITDA of ERNA is -$39.07 M
What is the all time high TTM EBITDA for Eterna Therapeutics?
Eterna Therapeutics all-time high TTM EBITDA is -$991.50 K
What is Eterna Therapeutics TTM EBITDA year-on-year change?
Over the past year, ERNA TTM EBITDA has changed by -$19.67 M (-101.41%)